Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF

By sjmartinez • November 18, 2024

Sin MK, Allman RM, Faselis C, Aronow WS, Brown CJ, Lam PH, Wu WC, Zeng-Treitler Q, Patel SS, Raman VK, Zhang S, Sheriff HM, Morgan CJ, Heidenreich PA, Fonarow GC, Ahmed A. Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF. Am J Med. 2024 Nov 12:S0002-9343(24)00710-1. doi: 10.1016/j.amjmed.2024.10.019. Epub ahead of print. PMID: 39551174.

Tags: Cardiology/Epi, death, HFrEF, kidney failure, octogenarians, Publications, RAS Inhibitors, target dose

Orchestration of Endothelial and Osteogenic Marker Expression During Osteogenesis

Chen S, Zhao Y, Chen N, Wu X, Zhang L, Jing Z, Qi L, Cai X, Boström KI, Yao Y. Orchestration of Endothelial and Osteogenic[...]

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies

Keramida K, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Dent S, Drakaki A, Fuster JJ, Mamas MA, Okwuosa T, Scarfo L, Van Der Meer[...]

Regional heterogeneity and sex differences along the mouse aorta

Sveeggen TM, Kosmach A, Mitchell R, Brockmann BC, Meisinger TM, Stratman AN, Mack JJ, Cook JR, Bagher P. Regional heterogeneity and sex differences along the[...]